Replies to post #865 on RespireRx Pharmaceuticals Inc (RSPI)

[DewDiligence]

>Novartis getting into the act would be great, though we haven't seen any evidence of that, yet.<

I was just wondering out loud why they are not more active in an arena where they appear to be laggards.

Perhaps they were saving their discretionary money for the hepatitis market, where they’ve done deals with virtually every biotech player (except VRTX) who has something of consequence going on.